Chief Financial Officer (Cfo) Adacap International (A Novartis Company)
Current- Advanced Accelerator Applications (ADACAP) is a global pharmaceutical Novartis company specializing in the development and commercialization of innovative nuclear medicine therapies for the treatment of cancer.- Lead performance management for headquarter functions and Swiss domestic/export businesses, providing strategic leadership and guidance to the FP&A team.- Managed and executed Funds Flow initiatives, working closely with Novartis Group Tax on Transfer Pricing, Indirect Tax, and profitability monitoring.- Supported major transformation / M&A projects, including the integration of Radio Ligand Therapy into Novartis and preparation for Molecular Imaging separation- Directing monthly closing and reporting for ADACAP International, collaborating with the Financial Reporting & Accounting teams and implementing corrective actions for statutory profitability.